Search for: "NOVARTIS PHARMA V TEVA PHARMA"
Results 81 - 100
of 139
Sorted by Relevance
|
Sort by Date
11 Nov 2009, 4:02 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 Apr 2015, 10:56 am
It has been all quiet on the pharma patent front since the beginning of March (when the epic series of first instance decisions on Swiss form claims came to and end: see here, here, here and here), and so this moggy was delighted when there fell into his paws the decision of Mr Justice Arnold in Novartis v Focus, Actavis, Teva [2015] EWHC 1068 (Pat).The case concerns a transdermal patch for rivastigmine, which is acetylcholinesterase (AChE) inhibitor… [read post]
6 Jul 2011, 2:21 am
Teva Pharms. [read post]
27 Jul 2011, 1:01 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
29 Jul 2009, 6:45 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
8 Feb 2011, 10:51 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
24 Feb 2010, 2:11 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
24 Feb 2010, 2:11 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
2 Apr 2007, 9:52 pm
Mylan Trileptal: Novartis v. [read post]
28 Oct 2009, 6:15 am
Here is IP Think Tank's weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
28 Oct 2009, 6:15 am
Here is IP Think Tank's weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
28 Oct 2009, 7:15 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
14 Nov 2007, 8:59 pm
Teva Famvir: Novartis v. [read post]
15 Jul 2009, 5:15 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
25 Nov 2009, 12:00 pm
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
8 Jul 2009, 7:04 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
13 Mar 2009, 2:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
13 Dec 2021, 12:49 am
Teva also argued for good measure that the SPC was invalid under Article 3(a) and 3(d). [read post]
29 Dec 2010, 2:57 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
5 Apr 2023, 5:18 am
Similarly, Hacon HHJ stated in Teva v Novartis [2022] EWHC 2847 (Pat): “It seems that there was little or no interaction between Novartis’ three experts during the preparation of their evidence. [read post]
